In agreement with our results, some studies also showed that increased expression levels of GPI were associated with poor prognosis in patients with clear cell-renal cell carcinoma (11), lung carcinomas (10, 22), endometrial carcinoma (23), and BRCA (24). The gene discussed is GPI; the disease is endometrial carcinoma.